Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 4
2005 2
2006 5
2007 5
2008 3
2009 8
2010 12
2011 22
2012 23
2013 16
2014 14
2015 23
2016 32
2017 34
2018 32
2019 34
2020 34
2021 38
2022 47
2023 56
2024 71
2025 67
2026 57

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

586 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean congqiang zhang (47 results)?
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.
Campone M, De Laurentiis M, Jhaveri K, Hu X, Ladoire S, Patsouris A, Zamagni C, Cui J, Cazzaniga M, Cil T, Jerzak KJ, Fuentes C, Yoshinami T, Rodriguez-Lescure A, Sezer A, Fontana A, Guarneri V, Molckovsky A, Mouret-Reynier MA, Demirci U, Zhang Y, Valota O, Lu DR, Martignoni M, Parameswaran J, Zhi X, Hamilton EP; VERITAC-2 Study Group. Campone M, et al. Among authors: zhang y. N Engl J Med. 2025 Aug 7;393(6):556-568. doi: 10.1056/NEJMoa2505725. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454645 Clinical Trial.
Single-cell profile reveals the landscape of cardiac immunity and identifies a cardio-protective Ym-1hi neutrophil in myocardial ischemia-reperfusion injury.
Dong Y, Kang Z, Zhang Z, Zhang Y, Zhou H, Liu Y, Shuai X, Li J, Yin L, Wang X, Ma Y, Fan H, Jiang F, Lin Z, Ding C, Yun Jin K, Sarapultsev A, Li F, Zhang G, Xie T, Yin C, Cheng X, Luo S, Liu Y, Hu D. Dong Y, et al. Among authors: zhang y. Sci Bull (Beijing). 2024 Apr 15;69(7):949-967. doi: 10.1016/j.scib.2024.02.003. Epub 2024 Feb 7. Sci Bull (Beijing). 2024. PMID: 38395651 Free article.
Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial.
Wang C, Gu H, Huo X, Yuan B, Li S, Xu J, Jiang Y, Jing J, Yao X, Li Z, Long F, Ma Z, Zhuang X, Xu L, Jin Y, Huang W, Zhang Y, Wen J, Wang A, Pan Y, Ye W, Yu W, Cheng A, Wang M, Dong Q, Xu A, Wang N, Yang Y, Meng X, Liu L, Zhao X, Li H, Miao Z, Li Z, Wang Y; TASTE-2 investigators. Wang C, et al. Among authors: zhang y. BMJ. 2026 Jan 7;392:e086850. doi: 10.1136/bmj-2025-086850. BMJ. 2026. PMID: 41500725 Free PMC article. Clinical Trial.
Global burden and trends of lung cancer incidence and mortality.
Li C, Lei S, Ding L, Xu Y, Wu X, Wang H, Zhang Z, Gao T, Zhang Y, Li L. Li C, et al. Among authors: zhang y. Chin Med J (Engl). 2023 Jul 5;136(13):1583-1590. doi: 10.1097/CM9.0000000000002529. Chin Med J (Engl). 2023. PMID: 37027426 Free PMC article.
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Jiang Z, Ouyang Q, Sun T, Zhang Q, Teng Y, Cui J, Wang H, Yin Y, Wang X, Zhou X, Wang Y, Sun G, Wang J, Zhang L, Yang J, Qian J, Yan M, Liu X, Yi T, Cheng Y, Li M, Zang A, Wang S, Wang C, Wu X, Cheng J, Li H, Lin Y, Geng C, Gu K, Xie C, Xiong H, Wu X, Yang J, Li Q, Chen Y, Li F, Zhang A, Zhang Y, Wu Y, Nie J, Liu Q, Wang K, Mo X, Chen L, Pan Y, Fu P, Zhang H, Pang D, Sheng Y, Han Y, Wang H, Cang S, Luo X, Yu W, Deng R, Yang C, Keegan P. Jiang Z, et al. Among authors: zhang y. Nat Med. 2024 Jan;30(1):249-256. doi: 10.1038/s41591-023-02677-x. Epub 2024 Jan 8. Nat Med. 2024. PMID: 38191615 Clinical Trial.
Role of oxytocin in bone.
Wang T, Ye J, Zhang Y, Li J, Yang T, Wang Y, Jiang X, Yao Q. Wang T, et al. Among authors: zhang y. Front Endocrinol (Lausanne). 2024 Sep 3;15:1450007. doi: 10.3389/fendo.2024.1450007. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39290327 Free PMC article. Review.
ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Hu X, Zhang Q, Wang L, Zhang J, Ouyang Q, Wang X, Li W, Xie W, Tong Z, Wang S, Xu F, Sun T, Liu W, Chen Z, Wu J, Wang Y, Wang H, Yan M, Wang X, Wang J, Cao F, Du Y, Zhang Y, Chen L, Lu P, Sun S, Zhang R, Zang A, Nie X, Lei Y. Hu X, et al. Among authors: zhang y. Signal Transduct Target Ther. 2025 Feb 17;10(1):56. doi: 10.1038/s41392-025-02149-3. Signal Transduct Target Ther. 2025. PMID: 39956849 Free PMC article. Clinical Trial.
Medial patellofemoral ligament reconstruction: A review.
Zhang YQ, Zhang Z, Wu M, Zhou YD, Tao SL, Yang YL, Li Y, Liu JL, Li P, Teng YS, Guo YM. Zhang YQ, et al. Medicine (Baltimore). 2022 Jan 7;101(1):e28511. doi: 10.1097/MD.0000000000028511. Medicine (Baltimore). 2022. PMID: 35029909 Free PMC article. Review.
586 results